Skip to main content
Clinical Trials/NCT00064649
NCT00064649
Terminated
Phase 3

Minimally Invasive Surgical Therapy Consortium for Benign Prostatic Hyperplasia

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)7 sites in 1 country49 target enrollmentApril 2004

Overview

Phase
Phase 3
Intervention
Transurethral Needle Ablation (TUNA) Therapy
Conditions
Benign Prostatic Hyperplasia
Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Enrollment
49
Locations
7
Status
Terminated
Last Updated
16 years ago

Overview

Brief Summary

The primary objective of this randomized clinical trial is to determine the efficacy and safety of three treatments for benign prostatic hyperplasia (BPH): transurethral needle ablation (TUNA), transurethral microwave therapy (TUMT), and medical therapy with alfuzosin and finasteride.

Registry
clinicaltrials.gov
Start Date
April 2004
End Date
June 2006
Last Updated
16 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Male

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Arms & Interventions

2

Transurethral Needle Ablation (TUNA)

Intervention: Transurethral Needle Ablation (TUNA) Therapy

3

finasteride in a daily dose of 5 mg and alfuzosin in a daily dose of 10 mg

Intervention: Finasteride and Alfuzosin

1

Transurethral Microwave Thermotherapy (TUMT)

Intervention: Transurethral Microwave Thermotherapy (TUMT)

Outcomes

Primary Outcomes

Not specified

Study Sites (7)

Loading locations...

Similar Trials